NOVACYT SIGNS STRATEGIC ALLIANCE WITH CEPHEID FOR HPV DIAGNOSTICS IN LATIN AMERICA

strategic-alliance-agreement-with-cepheid Paris, France and Cambridge, UK – 4th October 2016 – Novacyt (ALTERNEXT: ALNOV), an international specialist in clinical diagnostics, today announces it has entered into a strategic alliance with Cepheid Inc., a leading international molecular diagnostics company, to introduce a complete Human Papillomavirus (HPV) diagnostic system into Latin America.

Visit Page

Novacyt provides a business update

business-update-pr-eng Expanding NovaPrep commercialisation activities Investment in key growth regions

Visit Page

Novacyt provides an R&D update on its initial molecular products pipeline

R&D Strategy Update PR ENGLISH Paris, France and Cambridge, UK – 5th September 2016 – Novacyt (ALTERNEXT: ALNOV), an international clinically focused diagnostics company, today provides a Research and Development (R&D) update following the completion of the acquisition of Primerdesign in May 2016. The integration of Primerdesign is progressing well, in line with the strategic

Visit Page